Source: Courtesy of Mike Barnes
Draft guidance from the National Institute for Health and Care Excellence on cannabis-based medical products (CBMPs) has been described as “restrictive and negative” by a doctor who has campaigned for greater access to medical cannabis.
Mike Barnes, a consultant neurologist and chair of the Medical Cannabis Clinicians’ Society, said the guidance would make it more difficult for doctors to issue prescriptions for medical cannabis.
The guidance, published on 8 August 2019, is the first to be published since medical cannabis was legalised in November 2018. As well as calling for more trials in CBMPs, NICE says patients with chronic pain should